Navegando por Palavras-chave "Hyperinsulinemia"

Agora exibindo 1 - 2 de 2
  • Imagem de Miniatura
    Item
    Acesso aberto (Open Access)
    Efeito da restrição proteica gestacional sobre parâmetros morfométricos e metabólicos e sobre o comportamento alimentar na prole de camundongos
    (Universidade Federal de São Paulo (UNIFESP), 2016-07-31) Silva, Luana Cristina de Almeida [UNIFESP]; D'Almeida, Vania [UNIFESP]; http://lattes.cnpq.br/7220411418339421; http://lattes.cnpq.br/0784370244797321; Universidade Federal de São Paulo (UNIFESP)
    Objective: The objective of this study was to analyze the metabolic and behavioral effects of fetal growth restriction (IUGR) caused by the deficiency of protein during intrauterine life before and after exposure to high-fat diet. Method: After protein restriction (5g protein / 100 g diet, HP diet) in the maternal diet offspring, it was compared with offspring of mothers receiving normal protein diet (20 g protein / 100 g diet, NP diet). After birth, all offspring were suckled by progenitors fed NP diet and, there was adoption of all litters by progenitors fed NP diet. In postnatal day (PND) 28 a total of 51 offspring were distributed into two groups according to the maternal diet, namely: control group (CT, HP maternal diet) and restriction group (RT, NP maternal diet). The offspring were accompanied for 2 months receiving NP diet and, after this period all of them were fed with a high-fat diet with high concentration of saturated fat (31g saturated fat, 100g diet, HL) for about 5 weeks. The body weights of the offspring were accompanied weekly from birth to the 1st month of life and, monthly from 1st month until euthanasia. The naso-anal length was measured in PND30 and PND60. Blood samples were collected in PND30, PND60 and PND90 to assess blood concentrations of glucose, total cholesterol and triglycerides in whole blood and plasma concentrations of insulin and leptin. The animals were subjected to behavioral tests: Novelty suppressed-feeding test and open field. After behavioral assessments, the animals were euthanized by decapitation and had blood, fat, liver, kidney and muscle collected. Data is presented as mean ± standard deviation. Results and conclusions: IUGR decreased the birth weight of offspring and this effect can be observed at other times throughout the study; in males, this restriction reduced the naso-anal growth and altered muscle mass and the proportion of fat after high fat diet consumption. After spending the period stipulated feeding only at HL diet, restricted animals showed elevated plasma insulin. Males and females RT group showed increased locomotor activity, restricted females also had fewer episodes of self-cleaning during behavioral 95 testing and showed a higher consumption of HL diet over time in relation to the females CT group. With these data, we can conclude that the deficiency in maternal nutrition delayed intrauterine growth, and this effect can interfere in the post-natal development, affecting morphometric parameters before and after consumption of a HL diet. After passing through metabolic challenge exposure (HL diet), restricted animals showed elevated plasma insulin, demonstrating that IUGR may influence metabolic signaling involved in energy homeostasis promoted by a nutritional imbalance.
  • Imagem de Miniatura
    Item
    Acesso aberto (Open Access)
    Improved glycemic control by acarbose therapy in hypertensive diabetic patients: effects on blood pressure and hormonal parameters
    (Associação Brasileira de Divulgação Científica, 2002-08-01) Rosenbaum, Paulo [UNIFESP]; Peres, Ricardo Botticini [UNIFESP]; Zanella, Maria Teresa [UNIFESP]; Ferreira, Sandra Roberta Gouvea [UNIFESP]; Universidade Federal de São Paulo (UNIFESP)
    A double-blind, randomized, placebo-controlled study was carried out on 44 hypertensive type 2 diabetic subjects previously treated by diet associated or not with sulfonylurea to assess the effects of acarbose-induced glycemic control on blood pressure (BP) and hormonal parameters. Before randomization and after a 22-week treatment period (100 to 300 mg/day), the subjects were submitted to a standard meal test and to 24-h ambulatory BP monitoring (ABPM) and had plasma glucose, glycosylated hemoglobin, lipid profile, insulin, proinsulin and leptin levels determined. Weight loss was found only in the acarbose-treated group (75.1 ± 11.6 to 73.1 ± 11.6 kg, P<0.01). Glycosylated hemoglobin decreased only in the acarbose group (6.4 ± 1.7 to 5.6 ± 1.9%, P<0.05). Fasting proinsulin decreased only in the acarbose group (23.4 ± 19.3 to 14.3 ± 13.6 pmol/l, P<0.05), while leptin decreased in both (placebo group: 26.3 ± 6.1 to 23.3 ± 9.4 and acarbose group: 25.0 ± 5.5 to 22.7 ± 7.9 ng/ml, P<0.05). When the subset of acarbose-treated patients who improved glycemic control was considered, significant reductions in diurnal systolic, diastolic and mean BP (102.3 ± 6.0 to 99.0 ± 6.6 mmHg, P<0.05) were found. Acarbose monotherapy or combined with sulfonylurea was effective in improving glycemic control in hypertensive diabetic patients. Acarbose-induced improvement in metabolic control may reduce BP in these patients. Our data did not suggest a direct action of acarbose on insulin resistance or leptin levels.